My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

53.42 -0.55 (-1.02%)

Streaming Delayed Price Updated: 10:43 AM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

34 35 Next >

2 Soaring Stocks With More Upside Potential ↗

July 21, 2023

Are these mid-cap stocks giants in the making?

Via The Motley Fool

Is Now a Good Time to Buy CRISPR Therapeutics? ↗

July 21, 2023

CRISPR shares have climbed more than 40% this year.

Via The Motley Fool

3 Tech Stocks to Watch for Groundbreaking Innovations in 2030 ↗

July 19, 2023

If you’re a speculative investor here are three companies that are on the leading edge of what may be groundbreaking innovations by 2030.

Via InvestorPlace

2 Monster Stocks to Buy Without Any Hesitation ↗

July 17, 2023

These players each bring in billions of dollars in earnings every year.

Via The Motley Fool

Cathie Wood Is Buying These 3 Growth Stocks Hand Over Fist. Should You? ↗

July 15, 2023

The captain of innovation-focused investing can't seem to get enough of these beaten-down growth stocks.

Via The Motley Fool

3 Pharma Stocks That AI is Loving in July ↗

July 13, 2023

Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.

Via InvestorPlace

2 Magnificient Growth Stocks to Buy in July ↗

July 13, 2023

These two growth stocks might be incredibly undervalued right now.

Via The Motley Fool

Vertex Pharmaceuticals Stock: Bear vs. Bull ↗

July 03, 2023

Vertex has reached a key moment in its story.

Via The Motley Fool

2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗

June 28, 2023

These companies are coming into their own.

Via The Motley Fool

2 No-Brainer Healthcare Stocks to Buy With $100 Right Now ↗

July 13, 2023

These stocks may not stay this low for long.

Via The Motley Fool

3 Top Biotech Stocks Defying the Bear Market ↗

July 13, 2023

Each has the potential to dramatically outperform the market.

Via The Motley Fool

3 Biotech Stocks to Buy for Long-Term Gains

July 13, 2023

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.

Via MarketBeat

Topics ETFs Economy

3 Things About Vertex Pharmaceuticals That Smart Investors Know ↗

July 12, 2023

Vertex shares have advanced about 20% so far this year.

Via The Motley Fool

2 Top Healthcare Stocks Defying the Bear Market ↗

July 11, 2023

These stocks are rising in the double digits -- and outperforming the S&P 500.

Via The Motley Fool

Sitting on Cash? These 2 Stocks Are Great Buys ↗

July 11, 2023

Coca-Cola and Vertex Pharmaceuticals are excellent choices to add to your portfolio for the long term.

Via The Motley Fool

3 Growth Stocks With 55% to 71% Upside, According to Wall Street ↗

July 09, 2023

Find out why investment bank analysts are so bullish on these stocks.

Via The Motley Fool

2 Growth Stocks That Might Be Too Cheap to Ignore ↗

July 06, 2023

The sky is the limit for these healthcare companies.

Via The Motley Fool

Thoughts For Thursday: Back From The Holiday With Caution ↗

July 06, 2023

Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.

Via Talk Markets

3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025 ↗

July 05, 2023

In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025

Via InvestorPlace

Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday ↗

July 03, 2023

Via Benzinga

3 Stocks That Every 20-Year-Old Should Buy Today ↗

July 02, 2023

When you’re just starting out in adult life, you have time on your side. Use it to your advantage with these stocks for young investors.

Via InvestorPlace

The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023 ↗

June 29, 2023

If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.

Via InvestorPlace

This 1 Problem Could Sink at Least 4 Gene-Editing Stocks ↗

June 29, 2023

Reaching profitability could be harder than investors expect.

Via The Motley Fool

2 Unstoppable Growth Stocks to Buy in 2023 and Beyond ↗

June 29, 2023

Both companies have therapies that should help grow revenue and earnings for years.

Via The Motley Fool

The Best Stocks to Invest $20,000 in Right Now ↗

June 28, 2023

You can invest in these companies with $20,000 -- or even a lot less.

Via The Motley Fool

Why Shares of Nkarta Are Slumping Tuesday ↗

June 27, 2023

The pharmaceutical stock dropped after announcing so-so clinical trial results.

Via The Motley Fool

Wall Street Estimates That CRISPR Therapeutics Stock Could Jump 49%. Here's Why That's Right. ↗

June 27, 2023

With two huge catalysts drawing near, its stock could go even higher.

Via The Motley Fool

What Is CRISPR And Why Should Your Portfolio Care? ↗

June 25, 2023

CRISPR Therapeutics continues to be at the forefront of CRISPR-based therapeutics development. It's the first, and largest, but not the only player.

Via Talk Markets

3 Monster Stocks in the Making to Buy Right Now ↗

June 25, 2023

They're not monsters now -- but just give them some time.

Via The Motley Fool

Alleged Industrial Espionage Makes an Interesting Story ↗

June 21, 2023

We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.

Via The Motley Fool

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.